MREO — Mereo BioPharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $92.24m
- $84.03m
- £36.46m
Annual cashflow statement for Mereo BioPharma, fiscal year end - December 31st, millions except per share.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | 20-F | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | -41.1 | -166 | 14.2 |
| Depreciation | ||||
| Non-Cash Items | — | 0.207 | 129 | -21.1 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | -6.6 | 7.02 | 0.98 |
| Change in Accounts Receivable | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | — | -45.9 | -28.3 | -5.24 |
| Capital Expenditures | — | -0.021 | -0.016 | -0.535 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | 43.3 | 1.51 | 0.114 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Sale of Intangible Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | 43.3 | 1.5 | -0.421 |
| Financing Cash Flow Items | — | -2.5 | -7.89 | -0.234 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | -5.71 | 34.7 | 77.7 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | — | -8.7 | 7.12 | 70.8 |